Are you ready to shape the commercial part of our early pipeline and make an impact by developing portfolio analyses that inform about the decisions at the senior management level? Would you like to apply your background in business and/ or science to assess business opportunities that will change the lives of millions living with Diabetes? Then you may be the ideal candidate for our open position as Associate Director, Diabetes New Product Planning (NPP) department. Join us for a life-changing career! The position
As an Associate Director, New Product Planning you will be commercially responsible for early pipeline projects within the Diabetes area.
You will work with the new product planning team to develop and deliver (amongst other things):
• Target product profile (TPP)
• Early positioning
• Estimation of sales and patient potential
• Full project valuations (NPV and eNPV) for mature projects The above will be based on collecting and conducting primary and secondary market research on market and stakeholder preferences and shaping these insights into actionable commercial recommendations. This position is a great opportunity to make your impact on a truly global scale by:
• Conducting commercial assessments to enable key project decisions and aligning these through the Early Commercial Team
• Driving commercial input for the Product Development Plan and creating financial valuations of assets as they prepare to enter Phase 2 clinical development
• Participating in portfolio assessments and development of commercial guidance to research, as well as contributing to the annual value assessment of the late-stage development portfolio. On a daily basis, you will work in a global context but interact primarily with headquarters functions across a diverse network of internal colleagues from Research & Development, Commercial, Market Access & Pricing, Strategic Finance, Regulatory, Medical, and Product Supply. You will report to the Director and Head of Diabetes NPP. Physical presence is required in our offices in Copenhagen (Søborg), Denmark- only candidates who are willing to commute to the Copenhagen Area will be considered.
You can expect some limited travel days per year. While this position is a maternity cover position from Jan. 1st, 2024 – Dec. 31st, 2024, there is still a possibility that it may be extended into a permanent role based on business needs and performance. Qualifications
To succeed in the role, you have:
• A Master’s degree in business or economics combined with extensive skills in natural science, or a scientific Master’s degree combined with strong commercial experience
• Minimum 5 years of experience working in a pharmaceutical company is required and only candidates with extensive experience in this field will be considered
• Experience working in a New Product Planning team or similar functions such as early portfolio or commercial analytics is preferred.
• Strong financial and analytical skills with a proven ability to translate analysis into insights and recommendations
• Excellent written and spoken English with strong communication skills
• Previous experience from working with/within: Diabetes or related therapy areas, analytical function in a Commercial team, or other key functions in the drug development value chain (e.g., R&D, Medical Affairs, Regulatory Affairs) would be advantageous. Excellent interpersonal skills are expected for this position, as it requires working with multiple stakeholders in the company. A track record of delivering high quality and finding new ways to achieve goals is also necessary. Being proactive and inspired by ways of working smarter is important. Additionally, you have demonstrated the ability to work individually as well as part of a team on multiple projects in parallel. About the department
The Diabetes Early Portfolio & Insights (EP&I) functional area sets the commercial direction for Novo Nordisk’s future drug portfolio within Diabetes. The EP&I area consists of departments covering New Product Planning, Competitive Intelligence, Therapy Area Strategy, Customer Insights, and Forecasting. Within the EP&I functional area, the NPP department holds the commercial responsibility for the early portfolio of projects across the therapeutic area. In the NPP department, you will join a team of 5, all with varying backgrounds across commercial, finance, science, and medical, and you will work in collaboration with the broader NPP team across all of Novo Nordisk’s therapy areas. Together with our good colleagues across Novo Nordisk, we are proud to be driving the long-term commercial success of Novo Nordisk. In the New Product Planning department, we are dedicated to delivering top-quality quantitative and qualitative commercial assessments to enable critical project and portfolio decisions. While sharing a pursuit of ambitious goals we’re focused on maintaining a healthy and creative work culture and work-life balance.

Working at Novo Nordisk At Novo Nordisk, we don’t wait for change. We drive it. That’s why we’re putting our almost a century's worth of industry experience into a new venture – Obesity Therapy. And we want you to be at the forefront of it all. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development to manufacturing, marketing, and sales – we’re all working to move the needle on patient care. Contact
Should you have questions about the position, please do not hesitate to contact Albert Jacobsen at [email protected] or +45 3079 7700. Deadline
November 5th We will review applications on an ongoing basis, so we encourage you to apply as soon as possible. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.